1-6 of 6
Robert Stuart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma

Jagadish Kummetha Venkata, Ningfei An, Robert Stuart, Luciano J. Costa, Houjian Cai, Woodrow Coker, Jin H. Song, Kiwana Gibbs, Terri Matson, Elizabeth Garrett-Mayer, Zhuang Wan, Besim Ogretmen, Charles Smith, Yubin Kang
Journal: Blood
Blood (2014) 124 (12): 1915–1925.
https://doi.org/10.1182/blood-2014-03-559385
Published: 2014
Includes: Supplemental data
Journal Articles

Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A

Arelis Salas, Suriyan Ponnusamy, Can E. Senkal, Marisa Meyers-Needham, Shanmugam Panneer Selvam, Sahar A. Saddoughi, Elif Apohan, R. David Sentelle, Charles Smith, Christopher R. Gault, Lina M. Obeid, Hesham M. El-Shewy, Joshua Oaks, Ramasamy Santhanam, Guido Marcucci, Yusuf Baran, Sandeep Mahajan, Daniel Fernandes, Robert Stuart, Danilo Perrotti, Besim Ogretmen
Journal: Blood
Blood (2011) 117 (22): 5941–5952.
https://doi.org/10.1182/blood-2010-08-300772
Published: 2011
Includes: Supplemental data
Journal Articles

Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse

Clinical Trials & Observations
Francis Giles, Norbert Vey, Daniel DeAngelo, Karen Seiter, Wendy Stock, Robert Stuart, Darinka Boskovic, Arnaud Pigneux, Martin Tallman, Joseph Brandwein, Jonathan Kell, Tadeusz Robak, Peter Staib, Xavier Thomas, Ann Cahill, Maher Albitar, Susan O'Brien
Journal: Blood
Blood (2009) 114 (19): 4027–4033.
https://doi.org/10.1182/blood-2009-06-229351
Published: 2009
Journal Articles

Activity and Mechanism of Action of AS1411 in Acute Myeloid Leukemia Cells.

Weiwei Chen, Vijayalakshmi Sridharan, Sridharan Soundararajan, Yoko Otake, Robert Stuart, David Jones, Daniel Fernandes
Journal: Blood
Blood (2007) 110 (11): 1604.
https://doi.org/10.1182/blood.V110.11.1604.1604
Published: 2007
Journal Articles

A Randomized, Open-Label Study of Lestaurtinib (CEP-701), an Oral FLT3 Inhibitor, Administered in Sequence with Chemotherapy in Patients with Relapsed AML Harboring FLT3 Activating Mutations: Clinical Response Correlates with Successful FLT3 Inhibition.

Mark Levis, MD, PhD, B. Douglas Smith, MD, Miloslav Beran, MD, Maria R. Baer, MD, Harry P. Erba, MD, Larry Cripe, MD, Steven Coutre, MD, Anjali Advani, MD, Alexander Perl, MD, Marcel Devetten, MD, Robert Stuart, MD, Martin S. Tallman, MD, Peter Brown, PhD, Lothar Tremmel, Donald Small, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 403.
https://doi.org/10.1182/blood.V106.11.403.403
Published: 2005
Journal Articles

Phase I Trial of Bortezomib (NSC 681239) and Flavopiridol (NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms.

Steven Grant, Daniel Sullivan, David Roodman, Robert Stuart, Edward B. Perkins, Viswanathan Ramakrishnan, John Wright, A. Dimitrios Colevas, John D. Roberts
Journal: Blood
Blood (2005) 106 (11): 3338.
https://doi.org/10.1182/blood.V106.11.3338.3338
Published: 2005